Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2250
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCanakci, Ebru-
dc.contributor.authorKaratas, Ahmet-
dc.contributor.authorYildiz, Ismail-
dc.date.accessioned2022-08-17T05:21:21Z-
dc.date.available2022-08-17T05:21:21Z-
dc.date.issued2019-
dc.identifier.urihttp://doi.org/10.4328/JCAM.6062-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/2250-
dc.description.abstractAim: The evaluation of the intravascular fluid status of critical patients is of significant importance. Many publications that suggest that measurement of the inferior vena cava diameter is successful in indicating volume status are available. In this study, we aimed to compare the efficacy of the commonly used scoring systems APACHE II, SOFA, and CPIS, the BUN/Cre ratio, and the inferior vena cava collapsibility index (IVC CI) in terms of mortality prediction among patients diagnosed with VAP. Material and Method: Fifty-seven patients who had bacteria isolation in the specimens of the lower respiratory tract were included in the study. The demographic characteristics, comorbid conditions of all patients were recorded. In addition, the biochemical parameters, BUN/Cre ratio, MDRD, APACHE II, SOFA, CPIS, and the final status of each patient were recorded. Results: There was a statistically significant relationship between IVC CI and BCR (p=0.003). A significant correlation was found between MDRD and BCR (p < 0.001). There was a positive correlation between procalcitonin and SOFA score (r=0.618, p < 0.001). An increase in the CPIS value increases mortality to 3.52 times (p =0.027). The mortality risk of those with an IVC CI value of 50 and above is 38.59 times greater than that of those with an IVC CI value below 50 (p=0.003). Discussion: Procalcitonin and CPIS may provide guidance for predicting mortality in patients with VAP. We believe that the calculation of the IVC CI value is a sensitive method for determining and monitoring fluid therapy in patients with VAP and in every patient admitted to the ICU.en_US
dc.language.isoengen_US
dc.publisherDERMAN MEDICAL PUBL, KARTALTEPE MAHALLESI, ATATURK BULVARI, ANKARA, 00000, TURKEYen_US
dc.relation.isversionof10.4328/JCAM.6062en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectVentilator-Associated Pneumonia; Inferior Vena Cava Collapsibility Index; BUN/Creatinin Ratio; Mortality; Intensive Care Uniteen_US
dc.titleBun/creatinine ratio and the inferior vena cava collapsibility index in ventilator associated pneumoniaen_US
dc.typearticleen_US
dc.relation.journalJOURNAL OF CLINICAL AND ANALYTICAL MEDICINEen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0001-5331-7325en_US
dc.contributor.authorID0000-0001-9095-6054en_US
dc.identifier.volume10en_US
dc.identifier.issue2en_US
dc.identifier.startpage145en_US
dc.identifier.endpage150en_US
Appears in Collections:Dahili Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.